#6 - Beyond the Hype: Real AI Strategy for MedTech Startups - Joseph Snyder & Cristiano Fontana

#8 - 2025 Mid-Year Healthcare Report Highlights - Joseph Snyder and Cristiano Fontana

https://www.hsbcinnovationbanking.com/us/en/business-stage/hsbc-healthcare-reports [https://www.hsbcinnovationbanking.com/us/en/business-stage/hsbc-healthcare-reports]  Hosts: Joseph Snyder Head of Talent and Co-Founder, Lifeblood https://www.linkedin.com/in/josephasnyder1/ [https://www.linkedin.com/in/josephasnyder1/] Cristiano Fontana Head of Advisory, Lifeblood https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/ [https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/] Guests: Jonathan Norris Managing Director, VC Relationship Managment, HSBC Innovation Banking Jonathan Norris is a Managing Director at HSBC Innovation, with over two decades of experience in the healthcare and life sciences sector. A former litigation attorney, Jonathan has been immersed in healthcare investing since 1999, with a particular focus on equity and debt strategy across BioPharma, Medical Devices, Diagnostics/Tools, and Digital Health. At HSBC Innovation, Jonathan advises both investors and executives by analyzing historical and current market trends, including venture investments, IPO activity, and M&A. He regularly supports C-level leadership with business planning, exit strategy, and access to capital, and is known for his insightful thought leadership on healthcare venture funding and deal flow. Jonathan has authored numerous analyses on the flow of capital into the healthcare ecosystem and continues to be a trusted voice in the industry, helping shape strategic decision-making for both startups and investors. https://www.linkedin.com/in/jonathan-norris-248556/ [https://www.linkedin.com/in/jonathan-norris-248556/]

#7 -The Atomic Program: From Vision To Venture - Joseph Snyder and Cristiano Fontana

Hosts: Joseph Snyder Head of Talent and Co-Founder, Lifeblood https://www.linkedin.com/in/josephasnyder1/ [https://www.linkedin.com/in/josephasnyder1/] Cristiano Fontana Head of Advisory, Lifeblood https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/ [https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/] Guests: Kavita Bouknight CEO, Match Health Collective Kavita Bouknight is the CEO of Match Health Collective which specializes in MedTech marketing, messaging, and design. Their work focuses on building compelling brand identities, developing cohesive visual design, crafting strategic messaging frameworks, and creating pitch-ready content and go-to-market strategies to drive visibility and accelerate adoption. https://www.linkedin.com/in/kavitabouknight/ [https://www.linkedin.com/in/kavitabouknight/]  Martin Gomez Partner, Goodwin Co-leading the MedTech and Artificial Intelligence practice across IP, company formation, licensing, fundraising, an strategic transactions or exits. From FDA expectations to real-world applications, we explore what’s hype, what’s real, and what founders need to know to integrate AI responsibly. Tune in as they explore how AI is shaping product development, regulatory hurdles, and investor expectations across the MedTech landscape. https://www.linkedin.com/in/martin-gomez-898556113/ [https://www.linkedin.com/in/martin-gomez-898556113/]

#6 - Beyond the Hype: Real AI Strategy for MedTech Startups - Joseph Snyder & Cristiano Fontana

Hosts:   Joseph Snyder   Head of Talent and Co-Founder, Lifeblood https://www.linkedin.com/in/josephasnyder1/ [https://www.linkedin.com/in/josephasnyder1/] Cristiano Fontana   Head of Advisory, Lifeblood  https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/ [https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/]   Guests: Darcy Bachert CEO, Prolucid Darcy Bachert is the Founder and CEO of Prolucid, an ISO-13485 certified software engineering firm that specializes in custom medical software development. Over the past 17 years Darcy has grown Prolucid to a team of 25, supporting innovative MedTech companies across the world in successfully bringing their applications and devices to market https://www.linkedin.com/in/darcybachert/ [https://www.linkedin.com/in/darcybachert/] Robert Hamilton CEO, NeuraSignal Inc. Robert is a seasoned healthcare entrepreneur, executive, and engineer with a deep commitment to driving transformative innovation in medicine. With a passion for aligning bold vision with high-performing teams, he has spent his career tackling some of the most complex challenges in healthcare. Robert’s vision and leadership continue to place NeuraSignal at the forefront of AI-powered neurodiagnostics, advancing the future of brain health. https://www.linkedin.com/in/hamiltonrobert/ [https://www.linkedin.com/in/hamiltonrobert/] Carmen Brown Senior Manager of Regulatory Affairs, Proxima Carmen Brown is a Senior Regulatory Affairs Manager at Proxima Clinical Research, Inc. with 10 years of work experience in the pharmaceutical and medical device industry.  Carmen has a master’s in public health and a bachelor’s degree in chemistry. At Proxima, Carmen has worked on both drug products and medical devices specializing in combination products. Her expertise spans a wide variety of therapeutic areas including oncology and IVDs that have included AI/ML.  https://www.linkedin.com/in/carmen-brown-068462a6/ [https://www.linkedin.com/in/carmen-brown-068462a6/]

#5 - Will AI Make or Break Your MedTech Startup? - Joseph Snyder & Cristiano Fontana

Hosts: Joseph Snyder Head of Talent and Co-Founder, Lifeblood https://www.linkedin.com/in/josephasnyder1/ [https://www.linkedin.com/in/josephasnyder1/] Cristiano Fontana Head of Advisory, Lifeblood https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/ [https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/] Guests: Darcy Bachert CEO, Prolucid Darcy Bachert is the Founder and CEO of Prolucid, an ISO-13485 certified software engineering firm that specializes in custom medical software development. Over the past 17 years Darcy has grown Prolucid to a team of 25, supporting innovative MedTech companies across the world in successfully bringing their applications and devices to market https://www.linkedin.com/in/darcybachert/ [https://www.linkedin.com/in/darcybachert/] Alex Condon COO, Matrix One Alex Condon is the former co-founder of Galen Data, a globally compliant medical device cloud platform that provides connectivity, centralizes data, and provides analytics for the next generation of medical device companies, acquired by Matrix one. https://www.linkedin.com/in/alexcondon/ [https://www.linkedin.com/in/alexcondon/] Marty Gomez Partner, Goodwin Marty Gomez co-leads the MedTech and Artificial Intelligence practice at Goodwin across IP, company formation, licensing, fundraising, an strategic transactions or exits.  https://www.linkedin.com/in/martin-gomez-898556113/ [https://www.linkedin.com/in/martin-gomez-898556113/]

#4 - Fundraising Through the Ecosystem - The Irish Model: Joseph Snyder & Cristiano Fontana

Hosts: Joseph Snyder Head of Talent and Co-Founder, Lifeblood https://www.linkedin.com/in/josephasnyder1/ [https://www.linkedin.com/in/josephasnyder1/] Cristiano Fontana Head of Advisory, Lifeblood https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/ [https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/] Guests: Tim Jones CEO, Symphysis Medical Tim Jones is the CEO of SymPhysis Medical, an Irish MedTech start-up developing innovative solutions for the management of pleural effusions. Prior to founding SymPhysis Medical, Tim held key roles at Medtronic, where he gained hands-on experience in global MedTech operations, product development, and market access strategies within one of the world’s leading medical technology companies. At SymPhysis, Tim has led the company from early-stage concept through clinical validation, securing private investment and highly competitive non-dilutive funding, while earning international recognition for advancing patient-centric design in MedTech innovation. https://www.linkedin.com/in/tim-jones-1a004040/ [https://www.linkedin.com/in/tim-jones-1a004040/] Daniel O-Mahony Partner, Seroba Daniel O’Mahony is a Partner at Seroba, where he leverages over two decades of experience in life sciences, spanning product development, strategic planning, licensing, corporate venturing, and intellectual property commercialisation. He began his investment career in corporate venture at Elan Corporation and later became a partner at Kernel Capital, before joining Seroba in 2009. With a strong foundation in both academia and technology transfer, Daniel previously held research and teaching roles at Trinity College Dublin, the Geisinger Clinic in Pennsylvania, and University College Dublin. He also led the Technology Transfer Office at the University of Galway, where he secured several high-value licensing agreements. https://www.linkedin.com/in/daniel-o-mahony-b02a1413/ [https://www.linkedin.com/in/daniel-o-mahony-b02a1413/] Joey Mason Venture Partner, Claret Capital Partners Joey Mason has spent 30 years working in life sciences as an investor, entrepreneur, financier, director, mentor and advisor. He is currently a Venture Partner at Claret Capital Partners, a London-based venture debt firms. Joey also serves as a Venture Advisor to Sofinnova Partners, one of Europe’s leading healthcare investment firm.  Joey has significant experience in most segments of the industry – medtech, pharma/ biotech, diagnostics, health IT and techbio. He has served on the boards of 20 private and public companies in Ireland, Europe and the USA and also on the board of EVCA (InvestEurope), the trade association for the private equity industry in Europe. In 2021, he co-founded Duplex Capital Partners to advise companies innovating in the digitalisation of life sciences. Prior to this he led a Life Science fund at M Ventures, Merck KGaA’s corporate venture arm, from 2018 – 2020 in Amsterdam, having spent 10 years at Delta Partners from 2004, where he was responsible for its most profitably exited investment.  https://www.linkedin.com/in/joey-mason/ [https://www.linkedin.com/in/joey-mason/]